Notably, MG2 showed positive enrichment for immune-activation pathways—including MHC-II antigen presentation, IFN-α/γ signaling, and broader cytokine signaling—suggesting an anti-tumor phenotype (Figures S9 and S10). Here, IFNA1 is linked to neoplasm.